Affinity Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Affinity Capital Advisors's AMGN Position: Q3 2026 in Review
Affinity Capital Advisors increased its Amgen (AMGN) stake by 4% in Q3 2026, buying an estimated $15.5K and bringing the position to 1,003 shares worth $416K. The position accounts for 0.05% of the portfolio, ranked #129.
Affinity Capital Advisors first reported a position in AMGN in Q4 2019 and has held it in 20 quarters since. 1,170 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Affinity Capital Advisors held 1,003 shares of Amgen worth $416K as of Q3 2026.
- Affinity Capital Advisors bought 39 Amgen shares in Q3 2026, an estimated $15.5K.
- Amgen made up 0.05% of Affinity Capital Advisors's portfolio in Q3 2026, its #129 holding.
- Affinity Capital Advisors first reported a position in Amgen in Q4 2019 and has held it in 20 quarters since.
- 1,170 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Affinity Capital Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.